怀孕早期和妊娠期糖尿病中饮食蛋白质:一个前性队列研究
Tingyu Luo1, Hongyan Chen2, Huixin Wei1
1School of Nursing, Guangdong Pharmaceutical University, Guangzhou, 510000, China.
Endocrine
|September 18, 2023
概括
植物蛋白摄入可能会降低妊娠期糖尿病的风险,而动物蛋白可能会增加孕妇的中国妇女. 总蛋白质摄入量与GDM风险没有显著关联.
科学领域:
- 营养科学 营养科学
- 孕产妇健康 孕产妇健康
- 流行病学 流行病学
背景情况:
- 饮食中的蛋白质与妊娠期糖尿病 (GDM) 之间的联系尚不清楚.
- 了解蛋白质来源对于GDM预防策略至关重要.
研究的目的:
- 调查来自各种来源的饮食蛋白质摄入量与中国孕妇GDM风险之间的关联.
- 澄清动物蛋白与植物蛋白在GDM发展中的作用.
主要方法:
- 对1060名孕妇进行前性队列研究.
- 怀孕早期通过食物频率调查问卷评估的饮食蛋白质摄入量.
- 使用口服葡萄糖耐受性测试进行GDM诊断;用于分析的后勤回归和受限制的立方线.
主要成果:
- 26.3%的参与者发展了GDM.
- 较高的动物蛋白摄入量与增加的GDM风险相关 (或2.78).
- 较高的植物蛋白摄入量与降低GDM风险相关 (OR 0.43). 总蛋白质摄入量与GDM没有显著关联.
结论:
- 饮食中的植物蛋白摄入与降低GDM风险有关.
- 饮食中的动物蛋白摄入量与怀孕早期的GDM风险有关.
- 这些发现表明,以植物为基础的饮食方法可能对预防GDM有益.
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
2.5K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.5K
Pathophysiology of Diabetes
980
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
980
Diabetes Mellitus: Overview and Type I Subtype
2.7K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.7K
Diabetes: Symptoms, Diagnosis, and Complications
581
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
581
Dipeptidyl Peptidase 4 Inhibitors
211
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
211
Insulin: Dosing Regimen and Adverse Effects
205
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
205


